Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Free Radical Research|July 26, 2011
Cellular uptake mechanisms and responses to NO transferred from mono- and poly-S-nitrosated human serum albuminYu Ishima, Fumika Yoshida, Ulrich Kragh-Hansen, et al.Biochimica Et Biophysica Acta|April 29, 2014
N-acetyl-l-methionine is a superior protectant of human serum albumin against photo-oxidation and reactive oxygen species compared to N-acetyl-L-tryptophanYousuke Kouno, Makoto Anraku, Keishi Yamasaki, et al.Biochemistry and Biophysics Reports|September 29, 2017
N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophanYousuke Kouno, Makoto Anraku, Keishi Yamasaki, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2004
Structural analysis and fatty acid-binding properties of two Croatian variants of human serum albuminUlrich Kragh-Hansen, Monica Campagnoli, Slavica Dodig, et al.Biochimica Et Biophysica Acta|January 19, 2013
Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatmentAi Minomo, Yu Ishima, Victor T G Chuang, et al.The FEBS Journal|September 3, 2011
Biological characteristics of two lysines on human serum albumin in the high-affinity binding of 4Z,15Z-bilirubin-IXα revealed by phage displayAi Minomo, Yu Ishima, Ulrich Kragh-Hansen, et al.Clinical Biochemistry|November 26, 2003
Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albuminMonica Campagnoli, Ulrich Kragh-Hansen, Anders Overgaard Pedersen, et al.Journal of Pharmaceutical Sciences|April 11, 2012
S-guanylation of human serum albumin is a unique posttranslational modification and results in a novel class of antibacterial agentsYu Ishima, Hitomi Hoshino, Takuya Shinagawa, et al.Journal of Pharmaceutical Sciences|May 22, 2014
Tuning of poly-S-nitrosated human serum albumin as superior antitumor nanomedicineYu Ishima, Jun Fang, Ulrich Kragh-Hansen, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 17, 2016
An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencingKonrad Bienk, Michael Lykke Hvam, Malgorzata Maria Pakula, et al.Pageof 6